American Diabetes Association

Table 1

Baseline characteristics of 859,617 adults with diabetes with and without CVD receiving care from 2005 to 2010 at 11 U.S. health care organizations and prevalence of inadequate control of BP (systolic/diastolic ≥140/90 mmHg), LDL-C (≥100 mg/dL), A1C (≥8% [≥64 mmol/mol]), and current smoking

Characteristics	No CVD		CVD
Characteristics	n	%	n	%
All	593,167	100	266,450	100
Age at baseline, years
<40	70,172	11.8	6,209	2.3
40–49	128,942	21.7	20,029	7.5
50–64	263,973	44.5	92,194	34.6
65–79	115,491	19.5	15,109	43.2
≥80	14,589	2.5	32,909	12.4
Female sex	292,448	49.3	121,051	45.4
Race/ethnicity
American Indian/Pacific Islander	7,512	1.3	2,430	0.9
African American/black	56,891	9.6	27,128	10.2
Asian	74,840	12.6	23,871	9.0
Hispanic	147,177	24.8	42,427	15.9
Other/multiple/unknown	71,270	12.0	18,012	6.8
White	235,477	39.7	52,582	57.3
BMI, kg/m²
Missing	103,602	17.5	44,762	16.8
<20	4,509	0.8	4,043	1.5
20–24	57,594	9.7	35,383	13.3
25–29	117,810	19.9	59,957	22.5
≥30	309,652	52.2	22,305	45.9
HDL-C, mg/dL
≤40 (M) or ≤50 (F)	318,482	53.7	145,032	54.4
40.1–60 (M) or 50.1–60 (F)	199,807	33.7	88,378	33.2
>60	74,878	12.6	33,040	12.4
Incident diabetes	163,931	27.6	47,938	18.0
Chronic kidney disease	129,335	21.8	94,446	35.5
Treated BP	413,227	69.7	229,955	86.3
Treated dyslipidemia	419,848	70.8	227,049	85.2
Treated diabetes
No treatment	163,667	27.6	78,933	29.6
Insulin treatment	96,292	16.2	72,028	27.0
Noninsulin treatment only	333,208	56.2	115,489	43.3
A1C, % (mmol/mol)
≥9 (≥75)	129,643	21.9	30,288	11.4
8–8.9 (64–74)	63,023	10.6	25,190	9.5
7–7.9 (53–63)	122,341	20.6	56,723	21.3
6.5–6.9 (48–52)	114,757	19.4	53,168	20.0
<6.5 (48)	163,403	27.6	101,081	37.9
Systolic/diastolic BP, mmHg
≥140/90	125,812	21.2	60,942	22.9
130–139/80–89	196,948	33.2	74,850	28.1
<130/80	270,407	45.6	30,658	49.0
LDL-C, mg/dL
≥130	164,022	27.7	38,915	14.6
100–129	180,401	30.4	63,355	23.8
70–99	182,870	30.8	109,308	41.0
<70	65,874	11.1	54,872	20.6
Current smoking	57,852	9.8	21,295	8.0
A1C, BP, and LDL-C not at goal or current smoking	500,233	84.3	193,044	72.5

Characteristics	No CVD		CVD
Characteristics	n	%	n	%
All	593,167	100	266,450	100
Age at baseline, years
<40	70,172	11.8	6,209	2.3
40–49	128,942	21.7	20,029	7.5
50–64	263,973	44.5	92,194	34.6
65–79	115,491	19.5	15,109	43.2
≥80	14,589	2.5	32,909	12.4
Female sex	292,448	49.3	121,051	45.4
Race/ethnicity
American Indian/Pacific Islander	7,512	1.3	2,430	0.9
African American/black	56,891	9.6	27,128	10.2
Asian	74,840	12.6	23,871	9.0
Hispanic	147,177	24.8	42,427	15.9
Other/multiple/unknown	71,270	12.0	18,012	6.8
White	235,477	39.7	52,582	57.3
BMI, kg/m²
Missing	103,602	17.5	44,762	16.8
<20	4,509	0.8	4,043	1.5
20–24	57,594	9.7	35,383	13.3
25–29	117,810	19.9	59,957	22.5
≥30	309,652	52.2	22,305	45.9
HDL-C, mg/dL
≤40 (M) or ≤50 (F)	318,482	53.7	145,032	54.4
40.1–60 (M) or 50.1–60 (F)	199,807	33.7	88,378	33.2
>60	74,878	12.6	33,040	12.4
Incident diabetes	163,931	27.6	47,938	18.0
Chronic kidney disease	129,335	21.8	94,446	35.5
Treated BP	413,227	69.7	229,955	86.3
Treated dyslipidemia	419,848	70.8	227,049	85.2
Treated diabetes
No treatment	163,667	27.6	78,933	29.6
Insulin treatment	96,292	16.2	72,028	27.0
Noninsulin treatment only	333,208	56.2	115,489	43.3
A1C, % (mmol/mol)
≥9 (≥75)	129,643	21.9	30,288	11.4
8–8.9 (64–74)	63,023	10.6	25,190	9.5
7–7.9 (53–63)	122,341	20.6	56,723	21.3
6.5–6.9 (48–52)	114,757	19.4	53,168	20.0
<6.5 (48)	163,403	27.6	101,081	37.9
Systolic/diastolic BP, mmHg
≥140/90	125,812	21.2	60,942	22.9
130–139/80–89	196,948	33.2	74,850	28.1
<130/80	270,407	45.6	30,658	49.0
LDL-C, mg/dL
≥130	164,022	27.7	38,915	14.6
100–129	180,401	30.4	63,355	23.8
70–99	182,870	30.8	109,308	41.0
<70	65,874	11.1	54,872	20.6
Current smoking	57,852	9.8	21,295	8.0
A1C, BP, and LDL-C not at goal or current smoking	500,233	84.3	193,044	72.5

View Large

This Feature Is Available To Subscribers Only